Publication: Access and benefit sharing under the Nagoya protocol—quo vadis? Six Latin American case studies assessing opportunities and risk
Access and benefit sharing under the Nagoya protocol—quo vadis? Six Latin American case studies assessing opportunities and risk
Date
Date
Date
Citations
Heinrich, M., Scotti, F., Andrade-Cetto, A., Berger-Gonzalez, M., Echeverría, J., Friso, F., Garcia-Cardona, F., Hesketh, A., Hitziger, M., Maake, C., Politi, M., Spadafora, C., & Spadafora, R. (2020). Access and benefit sharing under the Nagoya protocol—quo vadis? Six Latin American case studies assessing opportunities and risk. Frontiers in Pharmacology, 11, 765. https://doi.org/10.3389/fphar.2020.00765
Abstract
Abstract
Abstract
Background: Global challenges related to access and benefit sharing (ABS) of biological resources have become a key concern in the area of research on herbal medicines, ethnopharmacology, drug discovery, and the development of other high value products for which Intellectual Property protection can be secured. While the Convention on Biological Diversity (CBD, Rio 1992) has been recognized as a huge step forward, the implementation of the Nagoya Protocol (NP) and of new forms of collaboration often remain unresolved, especially in the
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Page range/Item number
Page range/Item number
Page range/Item number
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Heinrich, M., Scotti, F., Andrade-Cetto, A., Berger-Gonzalez, M., Echeverría, J., Friso, F., Garcia-Cardona, F., Hesketh, A., Hitziger, M., Maake, C., Politi, M., Spadafora, C., & Spadafora, R. (2020). Access and benefit sharing under the Nagoya protocol—quo vadis? Six Latin American case studies assessing opportunities and risk. Frontiers in Pharmacology, 11, 765. https://doi.org/10.3389/fphar.2020.00765